The Penrose leadership team is responsible for bringing our mission to life.
President and Chief Executive Officer
Dr. David Sherris brings over three decades of experience to the Penrose table in translational medicine involving basic research, pharmaceutics and diagnostics.
Chief Medical Officer
Dr. Gill is a practicing cardio-oncologist with extensive experience in healthcare management and is a founding member of Penrose TherapeuTx.
Chief Development Officer
Dr. Desai is a trained medical oncologist and hematologist with more than two decades of oncology clinical research expertise across all phases of drug development.
Director of Chemistry, Manufacturing, and Controls
Chief Financial Officer & Chief Operating Officer
Mr. Schutt has over a decade of experience in balance sheet optimization, corporate finance, investment banking, and business development with publicly traded and privately held financial institutions ranging from $250 million to $25 billion in assets. He is also a founding member of Penrose TherapeuTx.